Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 299341 - 299360 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Latvia | (L01EA01) imatinib (adm: O) | Imatinib Teva | 30 Apvalkotā tablete, 400 mg | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Myelodysplastic-Myeloproliferative Diseases;Hypereosinophilic Syndrome;Dermatofibrosarcoma | TevaB.V.,Netherlands / TevaPharmaceuticalWorksPrivateLimitedCompany,Hungary;TevaUKLtd.,UnitedKingdom;MerckleGmbH,Germany;TEVACzechIndustriess.r.o.,CzechRepublic;TevaPharmaB.V.,Netherlands;TevaOperationsPolandSp.zo.o.,Poland;TevaPharma,S.L.U.,Spain;PlivaCroatiaLtd.,Croatia |
| Latvia | (L01EA01) imatinib (adm: O) | Itivas 400 mg apvalkotās tabletes | 60 Apvalkotā tablete, 400 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | TADPharmaGmbH,Germany / KRKA,d.d.,Novomesto,Slovenia;TADPharmaGmbH,Germany;KRKA-FARMAd.o.o.,Croatia |
| Latvia | (L01EA02) dasatinib (adm: O) | Sprycel | 60 Apvalkotā tablete, 50 mg | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbPharmaEEIG,Ireland / Bristol-MyersSquibbS.A.,France;Bristol-MyersSquibbCompany.,Italy |
| Latvia | (L01EA02) dasatinib (adm: O) | Sprycel | 60 Apvalkotā tablete, 70 mg | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbPharmaEEIG,Ireland / Bristol-MyersSquibbS.A.,France;Bristol-MyersSquibbCompany.,Italy |
| Latvia | (L01EA03) nilotinib (adm: O) | Tasigna | 112 Kapsula, cietā, 150 mg | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited,Ireland / NovartisPharmaGmbH,Germany;Lekd.d.,PEProizvodnjaLendava,Slovenia |
| Latvia | (L01EA03) nilotinib (adm: O) | Tasigna | 112 Kapsula, cietā, 200 mg | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited,Ireland / NovartisPharmaGmbH,Germany;Lekd.d.,PEProizvodnjaLendava,Slovenia |
| Latvia | (L01EA03) nilotinib (adm: O) | Tasigna | 112 cietas kapsulas, 200 | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited;NovartisBalticsSIA / NovartisPharmaGmbH,Germany;Lekd.d.,PEProizvodnjaLendava,Slovenia |
| Latvia | (L01EA05) ponatinib (adm: O) | Iclusig | 30 Apvalkotā tablete, 15 mg | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid;Leukemia, Lymphoid | IncyteBiosciencesDistributionB.V.,Netherlands / HauptPharmaAmaregGmbH,Germany;TjoaPackNetherlandsB.V.,Netherlands;IncyteBiosciencesDistributionB.V.,Netherlands |
| Latvia | (L01EA05) ponatinib (adm: O) | Iclusig | 30 Apvalkotā tablete, 45 mg | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myeloid;Leukemia, Lymphoid | IncyteBiosciencesDistributionB.V.,Netherlands / HauptPharmaAmaregGmbH,Germany;TjoaPackNetherlandsB.V.,Netherlands;IncyteBiosciencesDistributionB.V.,Netherlands |
| Latvia | (L01EB01) gefitinib (adm: O) | Iressa | 30 Apvalkotā tablete, 250 mg | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB,Sweden / AstraZenecaAB,Sweden;AstraZenecaUKLimited,UnitedKingdom |
| Latvia | (L01EB02) erlotinib (adm: O) | Tarceva | 30 Apvalkotā tablete, 100 mg | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Pancreatic Neoplasms | CheplapharmRegistrationGmbH,Germany / RochePharmaAG,Germany |
| Latvia | (L01EB02) erlotinib (adm: O) | Erlotinib Viatris 150 mg apvalkotās tabletes | 30 Apvalkotā tablete, 150 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | ViatrisLimited,Ireland / RemedicaLtd.,Cyprus |
| Latvia | (L01EB02) erlotinib (adm: O) | Erlotinib Viatris 150 mg apvalkotās tabletes | 30 Apvalkotā tablete, 150 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | ViatrisLimited,Ireland / RemedicaLtd.,Cyprus |
| Latvia | (L01EB02) erlotinib (adm: O) | Tarceva | 30 Apvalkotā tablete, 150 mg | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Pancreatic Neoplasms | CheplapharmRegistrationGmbH,Germany / RochePharmaAG,Germany |
| Latvia | (L01EB03) afatinib (adm: O) | Giotrif | 28 Apvalkotā tablete, 50 mg | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BoehringerIngelheimInternationalGmbH,Germany / BoehringerIngelheimPharmaGmbH&Co.KG,Germany;BoehringerIngelheimFrance,France |
| Latvia | (L01EC02) dabrafenib (adm: O) | Tafinlar | 120 Kapsula, cietā, 50 mg | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NovartisEuropharmLimited,Ireland / NovartisPharmaGmbH,Germany;GlaxoWellcomeS.A.,Spain;LekPharmaceuticalsd.d.,Slovenia |
| Latvia | (L01EC02) dabrafenib (adm: O) | Tafinlar | 28 Kapsula, cietā, 75 mg | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NovartisEuropharmLimited,Ireland / NovartisPharmaGmbH,Germany;GlaxoWellcomeS.A.,Spain;LekPharmaceuticalsd.d.,Slovenia |
| Latvia | (L01EC03) encorafenib (adm: O) | Braftovi | 42 Kapsula, cietā, 75 mg | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | PierreFabreMedicament,France / PierreFabreMedicamentProduction-Progipharm,France |
| Latvia | (L01ED01) crizotinib (adm: O) | XALKORI | 60 Kapsula, cietā, 250 mg | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerEuropeMAEEIG,Belgium / PfizerManufacturingDeutschlandGmbH,Germany |
| Latvia | (L01EE01) trametinib (adm: O) | Mekinist | 30 Apvalkotā tablete, 0,5 mg | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NovartisEuropharmLimited,Ireland / NovartisPharmaGmbH,Germany;GlaxoWellcomeS.A.,Spain;LekPharmaceuticalsd.d.,Slovenia |
Pages
